{
 "drug": "Aprepitant Oral Powder for Suspension",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "04/08/2026",
 "dayN": 139,
 "cat": "Gastroenterology",
 "companies": [
  "Merck Sharp & Dohme LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "04/08/2026",
   "update_type": "New",
   "initial_posting_date": "04/08/2026",
   "package_ndc": "0006-3066-03",
   "generic_name": "Aprepitant Oral Powder for Suspension",
   "contact_info": "800-672-6372",
   "related_info": "To be discontinued in approximately early-September 2026.",
   "openfda": {
    "application_number": [
     "NDA207865"
    ],
    "brand_name": [
     "EMEND"
    ],
    "generic_name": [
     "APREPITANT"
    ],
    "manufacturer_name": [
     "Merck Sharp & Dohme LLC"
    ],
    "product_ndc": [
     "0006-3066",
     "0006-0461",
     "0006-0462",
     "0006-3862",
     "0006-0464"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "APREPITANT"
    ],
    "rxcui": [
     "403810",
     "403811",
     "404465",
     "404466",
     "644088",
     "644278",
     "754508",
     "754509",
     "1729308",
     "1729311"
    ],
    "spl_id": [
     "428f7828-6d1c-438b-a17d-b4af0700c740"
    ],
    "spl_set_id": [
     "696f9e80-9cae-403b-de9e-078343ce4713"
    ],
    "package_ndc": [
     "0006-0461-02",
     "0006-0461-01",
     "0006-0461-06",
     "0006-0461-12",
     "0006-0462-01",
     "0006-0462-06",
     "0006-3862-03",
     "0006-3862-13",
     "0006-0464-01",
     "0006-0464-10",
     "0006-0464-05",
     "0006-3066-01",
     "0006-3066-03"
    ],
    "nui": [
     "N0000010262",
     "N0000175786",
     "N0000182141",
     "N0000185507",
     "N0000185506"
    ],
    "pharm_class_moa": [
     "Neurokinin 1 Antagonists [MoA]",
     "Cytochrome P450 3A4 Inhibitors [MoA]",
     "Cytochrome P450 2C9 Inducers [MoA]",
     "Cytochrome P450 3A4 Inducers [MoA]"
    ],
    "pharm_class_epc": [
     "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
    ],
    "unii": [
     "1NF15YR6UY"
    ]
   },
   "update_date": "04/08/2026",
   "therapeutic_category": [
    "Gastroenterology"
   ],
   "presentation": "Emend, Oral Powder for Suspension, 125 mg (NDC 0006-3066-03)",
   "company_name": "Merck Sharp & Dohme LLC",
   "status": "To Be Discontinued"
  }
 ]
}